Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | ZSCAN25 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ZSCAN26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZSCAN9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ZSWIM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZSWIM4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |